nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—azoospermia—testicular cancer	0.794	1	CtDrD
Clomifene—CYP2A6—Ifosfamide—testicular cancer	0.0366	0.338	CbGbCtD
Clomifene—CYP2E1—Etoposide—testicular cancer	0.0115	0.107	CbGbCtD
Clomifene—ABCB1—Dactinomycin—testicular cancer	0.0103	0.0955	CbGbCtD
Clomifene—CYP11A1—corpus luteum—testicular cancer	0.00996	0.224	CbGeAlD
Clomifene—CYP11A1—seminiferous tubule of testis—testicular cancer	0.00844	0.19	CbGeAlD
Clomifene—CYP3A4—Ifosfamide—testicular cancer	0.00731	0.0676	CbGbCtD
Clomifene—CYP1A2—Etoposide—testicular cancer	0.00667	0.0616	CbGbCtD
Clomifene—ABCB1—Vinblastine—testicular cancer	0.00648	0.0598	CbGbCtD
Clomifene—CYP19A1—corpus luteum—testicular cancer	0.00647	0.146	CbGeAlD
Clomifene—ABCB1—Cisplatin—testicular cancer	0.00594	0.0548	CbGbCtD
Clomifene—ABCB1—Etoposide—testicular cancer	0.00583	0.0539	CbGbCtD
Clomifene—CYP19A1—seminiferous tubule of testis—testicular cancer	0.00548	0.124	CbGeAlD
Clomifene—ABCB1—Doxorubicin—testicular cancer	0.00398	0.0368	CbGbCtD
Clomifene—CYP3A4—Vinblastine—testicular cancer	0.00388	0.0358	CbGbCtD
Clomifene—ABCB1—Methotrexate—testicular cancer	0.00385	0.0356	CbGbCtD
Clomifene—CYP3A4—Etoposide—testicular cancer	0.0035	0.0323	CbGbCtD
Clomifene—CYP19A1—semen—testicular cancer	0.00303	0.0683	CbGeAlD
Clomifene—CYP3A4—Doxorubicin—testicular cancer	0.00238	0.022	CbGbCtD
Clomifene—CYP2A6—seminal vesicle—testicular cancer	0.000819	0.0185	CbGeAlD
Clomifene—CYP11A1—gonad—testicular cancer	0.000715	0.0161	CbGeAlD
Clomifene—SIGMAR1—seminal vesicle—testicular cancer	0.000632	0.0142	CbGeAlD
Clomifene—ESR1—embryo—testicular cancer	0.000594	0.0134	CbGeAlD
Clomifene—CYP11A1—female gonad—testicular cancer	0.000581	0.0131	CbGeAlD
Clomifene—CYP11A1—testis—testicular cancer	0.000515	0.0116	CbGeAlD
Clomifene—KCNH2—seminal vesicle—testicular cancer	0.000503	0.0113	CbGeAlD
Clomifene—CYP19A1—gonad—testicular cancer	0.000464	0.0105	CbGeAlD
Clomifene—ESR1—gonad—testicular cancer	0.000404	0.00909	CbGeAlD
Clomifene—CYP2E1—seminal vesicle—testicular cancer	0.000387	0.00872	CbGeAlD
Clomifene—CYP19A1—female gonad—testicular cancer	0.000377	0.0085	CbGeAlD
Clomifene—CYP11A1—lymph node—testicular cancer	0.000373	0.00841	CbGeAlD
Clomifene—SIGMAR1—female gonad—testicular cancer	0.000371	0.00836	CbGeAlD
Clomifene—CYP19A1—testis—testicular cancer	0.000335	0.00754	CbGeAlD
Clomifene—SIGMAR1—testis—testicular cancer	0.000329	0.00741	CbGeAlD
Clomifene—ESR1—female gonad—testicular cancer	0.000328	0.00739	CbGeAlD
Clomifene—KCNH2—female gonad—testicular cancer	0.000295	0.00665	CbGeAlD
Clomifene—ESR1—testis—testicular cancer	0.000291	0.00655	CbGeAlD
Clomifene—KCNH2—testis—testicular cancer	0.000262	0.0059	CbGeAlD
Clomifene—CYP1A1—female gonad—testicular cancer	0.000249	0.00562	CbGeAlD
Clomifene—CYP19A1—lymph node—testicular cancer	0.000243	0.00547	CbGeAlD
Clomifene—SIGMAR1—lymph node—testicular cancer	0.000238	0.00537	CbGeAlD
Clomifene—ABCB1—embryo—testicular cancer	0.000235	0.00529	CbGeAlD
Clomifene—ABCB1—seminal vesicle—testicular cancer	0.000221	0.00497	CbGeAlD
Clomifene—ESR1—lymph node—testicular cancer	0.000211	0.00475	CbGeAlD
Clomifene—CYP2E1—testis—testicular cancer	0.000202	0.00454	CbGeAlD
Clomifene—KCNH2—lymph node—testicular cancer	0.00019	0.00428	CbGeAlD
Clomifene—CYP1A1—lymph node—testicular cancer	0.00016	0.00361	CbGeAlD
Clomifene—ABCB1—gonad—testicular cancer	0.000159	0.00359	CbGeAlD
Clomifene—ABCB1—female gonad—testicular cancer	0.00013	0.00292	CbGeAlD
Clomifene—ABCB1—testis—testicular cancer	0.000115	0.00259	CbGeAlD
Clomifene—Visual disturbance—Methotrexate—testicular cancer	8.6e-05	0.00162	CcSEcCtD
Clomifene—Pain—Bleomycin—testicular cancer	8.48e-05	0.00159	CcSEcCtD
Clomifene—Oedema—Ifosfamide—testicular cancer	8.47e-05	0.00159	CcSEcCtD
Clomifene—Eye pain—Epirubicin—testicular cancer	8.45e-05	0.00159	CcSEcCtD
Clomifene—Mental disability—Doxorubicin—testicular cancer	8.44e-05	0.00158	CcSEcCtD
Clomifene—Vision blurred—Cisplatin—testicular cancer	8.43e-05	0.00158	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Dactinomycin—testicular cancer	8.42e-05	0.00158	CcSEcCtD
Clomifene—Asthenia—Vinblastine—testicular cancer	8.42e-05	0.00158	CcSEcCtD
Clomifene—ABCB1—lymph node—testicular cancer	8.33e-05	0.00188	CbGeAlD
Clomifene—Alopecia—Etoposide—testicular cancer	8.32e-05	0.00156	CcSEcCtD
Clomifene—Cerebrovascular accident—Methotrexate—testicular cancer	8.32e-05	0.00156	CcSEcCtD
Clomifene—Phlebitis—Doxorubicin—testicular cancer	8.19e-05	0.00154	CcSEcCtD
Clomifene—Hot flush—Epirubicin—testicular cancer	8.16e-05	0.00153	CcSEcCtD
Clomifene—Thrombophlebitis—Doxorubicin—testicular cancer	8.16e-05	0.00153	CcSEcCtD
Clomifene—Vomiting—Chlorambucil—testicular cancer	8.14e-05	0.00153	CcSEcCtD
Clomifene—Increased appetite—Epirubicin—testicular cancer	8.12e-05	0.00152	CcSEcCtD
Clomifene—Menopausal symptoms—Epirubicin—testicular cancer	8.09e-05	0.00152	CcSEcCtD
Clomifene—Diarrhoea—Vinblastine—testicular cancer	8.03e-05	0.00151	CcSEcCtD
Clomifene—Fatigue—Dactinomycin—testicular cancer	7.97e-05	0.0015	CcSEcCtD
Clomifene—Back pain—Etoposide—testicular cancer	7.93e-05	0.00149	CcSEcCtD
Clomifene—Pain—Dactinomycin—testicular cancer	7.9e-05	0.00148	CcSEcCtD
Clomifene—Urticaria—Bleomycin—testicular cancer	7.87e-05	0.00148	CcSEcCtD
Clomifene—Body temperature increased—Bleomycin—testicular cancer	7.83e-05	0.00147	CcSEcCtD
Clomifene—Eye pain—Doxorubicin—testicular cancer	7.82e-05	0.00147	CcSEcCtD
Clomifene—Cerebrovascular accident—Epirubicin—testicular cancer	7.79e-05	0.00146	CcSEcCtD
Clomifene—Irritability—Methotrexate—testicular cancer	7.78e-05	0.00146	CcSEcCtD
Clomifene—Dizziness—Vinblastine—testicular cancer	7.76e-05	0.00146	CcSEcCtD
Clomifene—Convulsion—Cisplatin—testicular cancer	7.75e-05	0.00146	CcSEcCtD
Clomifene—Mood swings—Methotrexate—testicular cancer	7.72e-05	0.00145	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Ifosfamide—testicular cancer	7.72e-05	0.00145	CcSEcCtD
Clomifene—Diplopia—Epirubicin—testicular cancer	7.63e-05	0.00143	CcSEcCtD
Clomifene—Myalgia—Cisplatin—testicular cancer	7.62e-05	0.00143	CcSEcCtD
Clomifene—Nausea—Chlorambucil—testicular cancer	7.61e-05	0.00143	CcSEcCtD
Clomifene—Paraesthesia—Ifosfamide—testicular cancer	7.61e-05	0.00143	CcSEcCtD
Clomifene—Anxiety—Cisplatin—testicular cancer	7.59e-05	0.00143	CcSEcCtD
Clomifene—Dyspnoea—Ifosfamide—testicular cancer	7.55e-05	0.00142	CcSEcCtD
Clomifene—Hot flush—Doxorubicin—testicular cancer	7.55e-05	0.00142	CcSEcCtD
Clomifene—Increased appetite—Doxorubicin—testicular cancer	7.51e-05	0.00141	CcSEcCtD
Clomifene—Migraine—Epirubicin—testicular cancer	7.51e-05	0.00141	CcSEcCtD
Clomifene—Affect lability—Epirubicin—testicular cancer	7.51e-05	0.00141	CcSEcCtD
Clomifene—Menopausal symptoms—Doxorubicin—testicular cancer	7.48e-05	0.0014	CcSEcCtD
Clomifene—Vomiting—Vinblastine—testicular cancer	7.46e-05	0.0014	CcSEcCtD
Clomifene—Vertigo—Etoposide—testicular cancer	7.36e-05	0.00138	CcSEcCtD
Clomifene—Headache—Vinblastine—testicular cancer	7.35e-05	0.00138	CcSEcCtD
Clomifene—Body temperature increased—Dactinomycin—testicular cancer	7.31e-05	0.00137	CcSEcCtD
Clomifene—Fatigue—Ifosfamide—testicular cancer	7.3e-05	0.00137	CcSEcCtD
Clomifene—Oedema—Cisplatin—testicular cancer	7.3e-05	0.00137	CcSEcCtD
Clomifene—Hypersensitivity—Bleomycin—testicular cancer	7.3e-05	0.00137	CcSEcCtD
Clomifene—Pain—Ifosfamide—testicular cancer	7.24e-05	0.00136	CcSEcCtD
Clomifene—Constipation—Ifosfamide—testicular cancer	7.24e-05	0.00136	CcSEcCtD
Clomifene—Mood swings—Epirubicin—testicular cancer	7.23e-05	0.00136	CcSEcCtD
Clomifene—Loss of consciousness—Etoposide—testicular cancer	7.2e-05	0.00135	CcSEcCtD
Clomifene—Cerebrovascular accident—Doxorubicin—testicular cancer	7.2e-05	0.00135	CcSEcCtD
Clomifene—Tachycardia—Cisplatin—testicular cancer	7.13e-05	0.00134	CcSEcCtD
Clomifene—Asthenia—Bleomycin—testicular cancer	7.11e-05	0.00134	CcSEcCtD
Clomifene—Convulsion—Etoposide—testicular cancer	7.1e-05	0.00133	CcSEcCtD
Clomifene—Hypertension—Etoposide—testicular cancer	7.08e-05	0.00133	CcSEcCtD
Clomifene—Diplopia—Doxorubicin—testicular cancer	7.06e-05	0.00133	CcSEcCtD
Clomifene—Pruritus—Bleomycin—testicular cancer	7.01e-05	0.00132	CcSEcCtD
Clomifene—Chest pain—Etoposide—testicular cancer	6.98e-05	0.00131	CcSEcCtD
Clomifene—Nausea—Vinblastine—testicular cancer	6.97e-05	0.00131	CcSEcCtD
Clomifene—Migraine—Doxorubicin—testicular cancer	6.95e-05	0.0013	CcSEcCtD
Clomifene—Affect lability—Doxorubicin—testicular cancer	6.95e-05	0.0013	CcSEcCtD
Clomifene—Pancreatitis—Methotrexate—testicular cancer	6.91e-05	0.0013	CcSEcCtD
Clomifene—Hypersensitivity—Dactinomycin—testicular cancer	6.81e-05	0.00128	CcSEcCtD
Clomifene—Abdominal discomfort—Methotrexate—testicular cancer	6.76e-05	0.00127	CcSEcCtD
Clomifene—Urticaria—Ifosfamide—testicular cancer	6.73e-05	0.00126	CcSEcCtD
Clomifene—Body temperature increased—Ifosfamide—testicular cancer	6.7e-05	0.00126	CcSEcCtD
Clomifene—Mood swings—Doxorubicin—testicular cancer	6.69e-05	0.00126	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Cisplatin—testicular cancer	6.65e-05	0.00125	CcSEcCtD
Clomifene—Abdominal distension—Epirubicin—testicular cancer	6.64e-05	0.00125	CcSEcCtD
Clomifene—Asthenia—Dactinomycin—testicular cancer	6.63e-05	0.00125	CcSEcCtD
Clomifene—Paraesthesia—Cisplatin—testicular cancer	6.56e-05	0.00123	CcSEcCtD
Clomifene—Tachycardia—Etoposide—testicular cancer	6.53e-05	0.00123	CcSEcCtD
Clomifene—Dyspnoea—Cisplatin—testicular cancer	6.51e-05	0.00122	CcSEcCtD
Clomifene—Pancreatitis—Epirubicin—testicular cancer	6.47e-05	0.00121	CcSEcCtD
Clomifene—Diarrhoea—Dactinomycin—testicular cancer	6.32e-05	0.00119	CcSEcCtD
Clomifene—Vomiting—Bleomycin—testicular cancer	6.3e-05	0.00118	CcSEcCtD
Clomifene—Rash—Bleomycin—testicular cancer	6.25e-05	0.00117	CcSEcCtD
Clomifene—Pain—Cisplatin—testicular cancer	6.24e-05	0.00117	CcSEcCtD
Clomifene—Dermatitis—Bleomycin—testicular cancer	6.24e-05	0.00117	CcSEcCtD
Clomifene—Hypersensitivity—Ifosfamide—testicular cancer	6.24e-05	0.00117	CcSEcCtD
Clomifene—Renal failure—Methotrexate—testicular cancer	6.18e-05	0.00116	CcSEcCtD
Clomifene—Abdominal distension—Doxorubicin—testicular cancer	6.14e-05	0.00115	CcSEcCtD
Clomifene—Pollakiuria—Epirubicin—testicular cancer	6.09e-05	0.00114	CcSEcCtD
Clomifene—Asthenia—Ifosfamide—testicular cancer	6.08e-05	0.00114	CcSEcCtD
Clomifene—Paraesthesia—Etoposide—testicular cancer	6.01e-05	0.00113	CcSEcCtD
Clomifene—Weight increased—Epirubicin—testicular cancer	6e-05	0.00113	CcSEcCtD
Clomifene—Pruritus—Ifosfamide—testicular cancer	5.99e-05	0.00113	CcSEcCtD
Clomifene—Pancreatitis—Doxorubicin—testicular cancer	5.98e-05	0.00112	CcSEcCtD
Clomifene—Dyspnoea—Etoposide—testicular cancer	5.96e-05	0.00112	CcSEcCtD
Clomifene—Nausea—Bleomycin—testicular cancer	5.89e-05	0.00111	CcSEcCtD
Clomifene—Vomiting—Dactinomycin—testicular cancer	5.88e-05	0.0011	CcSEcCtD
Clomifene—Rash—Dactinomycin—testicular cancer	5.83e-05	0.00109	CcSEcCtD
Clomifene—Diarrhoea—Ifosfamide—testicular cancer	5.8e-05	0.00109	CcSEcCtD
Clomifene—Renal failure—Epirubicin—testicular cancer	5.78e-05	0.00109	CcSEcCtD
Clomifene—Body temperature increased—Cisplatin—testicular cancer	5.77e-05	0.00108	CcSEcCtD
Clomifene—Fatigue—Etoposide—testicular cancer	5.77e-05	0.00108	CcSEcCtD
Clomifene—Jaundice—Epirubicin—testicular cancer	5.73e-05	0.00108	CcSEcCtD
Clomifene—Constipation—Etoposide—testicular cancer	5.72e-05	0.00107	CcSEcCtD
Clomifene—Pain—Etoposide—testicular cancer	5.72e-05	0.00107	CcSEcCtD
Clomifene—Hepatitis—Methotrexate—testicular cancer	5.64e-05	0.00106	CcSEcCtD
Clomifene—Pollakiuria—Doxorubicin—testicular cancer	5.64e-05	0.00106	CcSEcCtD
Clomifene—Dizziness—Ifosfamide—testicular cancer	5.6e-05	0.00105	CcSEcCtD
Clomifene—Weight increased—Doxorubicin—testicular cancer	5.55e-05	0.00104	CcSEcCtD
Clomifene—Nausea—Dactinomycin—testicular cancer	5.49e-05	0.00103	CcSEcCtD
Clomifene—Visual impairment—Methotrexate—testicular cancer	5.44e-05	0.00102	CcSEcCtD
Clomifene—Vomiting—Ifosfamide—testicular cancer	5.39e-05	0.00101	CcSEcCtD
Clomifene—Hypersensitivity—Cisplatin—testicular cancer	5.38e-05	0.00101	CcSEcCtD
Clomifene—Renal failure—Doxorubicin—testicular cancer	5.35e-05	0.001	CcSEcCtD
Clomifene—Rash—Ifosfamide—testicular cancer	5.34e-05	0.001	CcSEcCtD
Clomifene—Dermatitis—Ifosfamide—testicular cancer	5.34e-05	0.001	CcSEcCtD
Clomifene—Erythema multiforme—Methotrexate—testicular cancer	5.33e-05	0.001	CcSEcCtD
Clomifene—Urticaria—Etoposide—testicular cancer	5.31e-05	0.000998	CcSEcCtD
Clomifene—Jaundice—Doxorubicin—testicular cancer	5.3e-05	0.000996	CcSEcCtD
Clomifene—Body temperature increased—Etoposide—testicular cancer	5.29e-05	0.000993	CcSEcCtD
Clomifene—Hepatitis—Epirubicin—testicular cancer	5.28e-05	0.000991	CcSEcCtD
Clomifene—Tinnitus—Methotrexate—testicular cancer	5.26e-05	0.000987	CcSEcCtD
Clomifene—Asthenia—Cisplatin—testicular cancer	5.24e-05	0.000984	CcSEcCtD
Clomifene—Visual impairment—Epirubicin—testicular cancer	5.09e-05	0.000955	CcSEcCtD
Clomifene—Nausea—Ifosfamide—testicular cancer	5.03e-05	0.000945	CcSEcCtD
Clomifene—Diarrhoea—Cisplatin—testicular cancer	5e-05	0.000938	CcSEcCtD
Clomifene—Erythema multiforme—Epirubicin—testicular cancer	4.99e-05	0.000937	CcSEcCtD
Clomifene—Alopecia—Methotrexate—testicular cancer	4.98e-05	0.000936	CcSEcCtD
Clomifene—Hypersensitivity—Etoposide—testicular cancer	4.93e-05	0.000925	CcSEcCtD
Clomifene—Tinnitus—Epirubicin—testicular cancer	4.92e-05	0.000924	CcSEcCtD
Clomifene—Erythema—Methotrexate—testicular cancer	4.91e-05	0.000922	CcSEcCtD
Clomifene—Flushing—Epirubicin—testicular cancer	4.9e-05	0.00092	CcSEcCtD
Clomifene—Hepatitis—Doxorubicin—testicular cancer	4.88e-05	0.000917	CcSEcCtD
Clomifene—Asthenia—Etoposide—testicular cancer	4.8e-05	0.000901	CcSEcCtD
Clomifene—Back pain—Methotrexate—testicular cancer	4.75e-05	0.000892	CcSEcCtD
Clomifene—Pruritus—Etoposide—testicular cancer	4.73e-05	0.000889	CcSEcCtD
Clomifene—Arrhythmia—Epirubicin—testicular cancer	4.72e-05	0.000885	CcSEcCtD
Clomifene—Visual impairment—Doxorubicin—testicular cancer	4.71e-05	0.000884	CcSEcCtD
Clomifene—Alopecia—Epirubicin—testicular cancer	4.66e-05	0.000876	CcSEcCtD
Clomifene—Vomiting—Cisplatin—testicular cancer	4.64e-05	0.000872	CcSEcCtD
Clomifene—Vision blurred—Methotrexate—testicular cancer	4.63e-05	0.000869	CcSEcCtD
Clomifene—Erythema multiforme—Doxorubicin—testicular cancer	4.62e-05	0.000867	CcSEcCtD
Clomifene—Rash—Cisplatin—testicular cancer	4.6e-05	0.000864	CcSEcCtD
Clomifene—Dermatitis—Cisplatin—testicular cancer	4.6e-05	0.000864	CcSEcCtD
Clomifene—Erythema—Epirubicin—testicular cancer	4.59e-05	0.000863	CcSEcCtD
Clomifene—Diarrhoea—Etoposide—testicular cancer	4.58e-05	0.000859	CcSEcCtD
Clomifene—Tinnitus—Doxorubicin—testicular cancer	4.55e-05	0.000855	CcSEcCtD
Clomifene—Flushing—Doxorubicin—testicular cancer	4.53e-05	0.000851	CcSEcCtD
Clomifene—Flatulence—Epirubicin—testicular cancer	4.53e-05	0.00085	CcSEcCtD
Clomifene—Tension—Epirubicin—testicular cancer	4.51e-05	0.000847	CcSEcCtD
Clomifene—Nervousness—Epirubicin—testicular cancer	4.46e-05	0.000838	CcSEcCtD
Clomifene—Back pain—Epirubicin—testicular cancer	4.44e-05	0.000835	CcSEcCtD
Clomifene—Dizziness—Etoposide—testicular cancer	4.42e-05	0.000831	CcSEcCtD
Clomifene—Vertigo—Methotrexate—testicular cancer	4.41e-05	0.000828	CcSEcCtD
Clomifene—Arrhythmia—Doxorubicin—testicular cancer	4.36e-05	0.000819	CcSEcCtD
Clomifene—Nausea—Cisplatin—testicular cancer	4.34e-05	0.000814	CcSEcCtD
Clomifene—Vision blurred—Epirubicin—testicular cancer	4.33e-05	0.000813	CcSEcCtD
Clomifene—Alopecia—Doxorubicin—testicular cancer	4.32e-05	0.00081	CcSEcCtD
Clomifene—Convulsion—Methotrexate—testicular cancer	4.25e-05	0.000799	CcSEcCtD
Clomifene—Vomiting—Etoposide—testicular cancer	4.25e-05	0.000799	CcSEcCtD
Clomifene—Erythema—Doxorubicin—testicular cancer	4.25e-05	0.000798	CcSEcCtD
Clomifene—Rash—Etoposide—testicular cancer	4.22e-05	0.000792	CcSEcCtD
Clomifene—Dermatitis—Etoposide—testicular cancer	4.21e-05	0.000791	CcSEcCtD
Clomifene—Headache—Etoposide—testicular cancer	4.19e-05	0.000787	CcSEcCtD
Clomifene—Flatulence—Doxorubicin—testicular cancer	4.19e-05	0.000787	CcSEcCtD
Clomifene—Myalgia—Methotrexate—testicular cancer	4.18e-05	0.000785	CcSEcCtD
Clomifene—Chest pain—Methotrexate—testicular cancer	4.18e-05	0.000785	CcSEcCtD
Clomifene—Arthralgia—Methotrexate—testicular cancer	4.18e-05	0.000785	CcSEcCtD
Clomifene—Tension—Doxorubicin—testicular cancer	4.17e-05	0.000783	CcSEcCtD
Clomifene—Nervousness—Doxorubicin—testicular cancer	4.13e-05	0.000775	CcSEcCtD
Clomifene—Vertigo—Epirubicin—testicular cancer	4.13e-05	0.000775	CcSEcCtD
Clomifene—Syncope—Epirubicin—testicular cancer	4.12e-05	0.000774	CcSEcCtD
Clomifene—Back pain—Doxorubicin—testicular cancer	4.11e-05	0.000772	CcSEcCtD
Clomifene—Palpitations—Epirubicin—testicular cancer	4.06e-05	0.000762	CcSEcCtD
Clomifene—Loss of consciousness—Epirubicin—testicular cancer	4.04e-05	0.000758	CcSEcCtD
Clomifene—Vision blurred—Doxorubicin—testicular cancer	4.01e-05	0.000752	CcSEcCtD
Clomifene—Convulsion—Epirubicin—testicular cancer	3.98e-05	0.000747	CcSEcCtD
Clomifene—Nausea—Etoposide—testicular cancer	3.97e-05	0.000746	CcSEcCtD
Clomifene—Hypertension—Epirubicin—testicular cancer	3.97e-05	0.000745	CcSEcCtD
Clomifene—Myalgia—Epirubicin—testicular cancer	3.91e-05	0.000734	CcSEcCtD
Clomifene—Chest pain—Epirubicin—testicular cancer	3.91e-05	0.000734	CcSEcCtD
Clomifene—Arthralgia—Epirubicin—testicular cancer	3.91e-05	0.000734	CcSEcCtD
Clomifene—Anxiety—Epirubicin—testicular cancer	3.9e-05	0.000732	CcSEcCtD
Clomifene—Vertigo—Doxorubicin—testicular cancer	3.82e-05	0.000717	CcSEcCtD
Clomifene—Syncope—Doxorubicin—testicular cancer	3.81e-05	0.000716	CcSEcCtD
Clomifene—Palpitations—Doxorubicin—testicular cancer	3.76e-05	0.000705	CcSEcCtD
Clomifene—Oedema—Epirubicin—testicular cancer	3.75e-05	0.000704	CcSEcCtD
Clomifene—Loss of consciousness—Doxorubicin—testicular cancer	3.74e-05	0.000702	CcSEcCtD
Clomifene—Shock—Epirubicin—testicular cancer	3.69e-05	0.000693	CcSEcCtD
Clomifene—Convulsion—Doxorubicin—testicular cancer	3.68e-05	0.000692	CcSEcCtD
Clomifene—Hypertension—Doxorubicin—testicular cancer	3.67e-05	0.000689	CcSEcCtD
Clomifene—Tachycardia—Epirubicin—testicular cancer	3.66e-05	0.000687	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Methotrexate—testicular cancer	3.65e-05	0.000685	CcSEcCtD
Clomifene—Insomnia—Methotrexate—testicular cancer	3.62e-05	0.00068	CcSEcCtD
Clomifene—Arthralgia—Doxorubicin—testicular cancer	3.62e-05	0.00068	CcSEcCtD
Clomifene—Myalgia—Doxorubicin—testicular cancer	3.62e-05	0.00068	CcSEcCtD
Clomifene—Chest pain—Doxorubicin—testicular cancer	3.62e-05	0.00068	CcSEcCtD
Clomifene—Anxiety—Doxorubicin—testicular cancer	3.61e-05	0.000677	CcSEcCtD
Clomifene—Paraesthesia—Methotrexate—testicular cancer	3.6e-05	0.000676	CcSEcCtD
Clomifene—Dyspnoea—Methotrexate—testicular cancer	3.57e-05	0.000671	CcSEcCtD
Clomifene—Oedema—Doxorubicin—testicular cancer	3.47e-05	0.000651	CcSEcCtD
Clomifene—Fatigue—Methotrexate—testicular cancer	3.45e-05	0.000649	CcSEcCtD
Clomifene—Pain—Methotrexate—testicular cancer	3.43e-05	0.000643	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Epirubicin—testicular cancer	3.42e-05	0.000641	CcSEcCtD
Clomifene—Shock—Doxorubicin—testicular cancer	3.41e-05	0.000641	CcSEcCtD
Clomifene—Insomnia—Epirubicin—testicular cancer	3.39e-05	0.000637	CcSEcCtD
Clomifene—Tachycardia—Doxorubicin—testicular cancer	3.39e-05	0.000636	CcSEcCtD
Clomifene—Paraesthesia—Epirubicin—testicular cancer	3.37e-05	0.000632	CcSEcCtD
Clomifene—Dyspnoea—Epirubicin—testicular cancer	3.34e-05	0.000628	CcSEcCtD
Clomifene—Fatigue—Epirubicin—testicular cancer	3.23e-05	0.000607	CcSEcCtD
Clomifene—Pain—Epirubicin—testicular cancer	3.21e-05	0.000602	CcSEcCtD
Clomifene—Constipation—Epirubicin—testicular cancer	3.21e-05	0.000602	CcSEcCtD
Clomifene—Urticaria—Methotrexate—testicular cancer	3.18e-05	0.000598	CcSEcCtD
Clomifene—Body temperature increased—Methotrexate—testicular cancer	3.17e-05	0.000595	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Doxorubicin—testicular cancer	3.16e-05	0.000594	CcSEcCtD
Clomifene—Insomnia—Doxorubicin—testicular cancer	3.14e-05	0.000589	CcSEcCtD
Clomifene—Paraesthesia—Doxorubicin—testicular cancer	3.12e-05	0.000585	CcSEcCtD
Clomifene—Dyspnoea—Doxorubicin—testicular cancer	3.09e-05	0.000581	CcSEcCtD
Clomifene—Fatigue—Doxorubicin—testicular cancer	2.99e-05	0.000562	CcSEcCtD
Clomifene—Urticaria—Epirubicin—testicular cancer	2.98e-05	0.000559	CcSEcCtD
Clomifene—Constipation—Doxorubicin—testicular cancer	2.97e-05	0.000557	CcSEcCtD
Clomifene—Pain—Doxorubicin—testicular cancer	2.97e-05	0.000557	CcSEcCtD
Clomifene—Body temperature increased—Epirubicin—testicular cancer	2.96e-05	0.000557	CcSEcCtD
Clomifene—Hypersensitivity—Methotrexate—testicular cancer	2.95e-05	0.000554	CcSEcCtD
Clomifene—Asthenia—Methotrexate—testicular cancer	2.88e-05	0.00054	CcSEcCtD
Clomifene—Pruritus—Methotrexate—testicular cancer	2.84e-05	0.000532	CcSEcCtD
Clomifene—Hypersensitivity—Epirubicin—testicular cancer	2.76e-05	0.000519	CcSEcCtD
Clomifene—Urticaria—Doxorubicin—testicular cancer	2.76e-05	0.000518	CcSEcCtD
Clomifene—Body temperature increased—Doxorubicin—testicular cancer	2.74e-05	0.000515	CcSEcCtD
Clomifene—Diarrhoea—Methotrexate—testicular cancer	2.74e-05	0.000515	CcSEcCtD
Clomifene—Asthenia—Epirubicin—testicular cancer	2.69e-05	0.000505	CcSEcCtD
Clomifene—Pruritus—Epirubicin—testicular cancer	2.65e-05	0.000498	CcSEcCtD
Clomifene—Dizziness—Methotrexate—testicular cancer	2.65e-05	0.000498	CcSEcCtD
Clomifene—Diarrhoea—Epirubicin—testicular cancer	2.57e-05	0.000482	CcSEcCtD
Clomifene—Hypersensitivity—Doxorubicin—testicular cancer	2.56e-05	0.00048	CcSEcCtD
Clomifene—Vomiting—Methotrexate—testicular cancer	2.55e-05	0.000478	CcSEcCtD
Clomifene—Rash—Methotrexate—testicular cancer	2.53e-05	0.000474	CcSEcCtD
Clomifene—Dermatitis—Methotrexate—testicular cancer	2.52e-05	0.000474	CcSEcCtD
Clomifene—Headache—Methotrexate—testicular cancer	2.51e-05	0.000471	CcSEcCtD
Clomifene—Asthenia—Doxorubicin—testicular cancer	2.49e-05	0.000467	CcSEcCtD
Clomifene—Dizziness—Epirubicin—testicular cancer	2.48e-05	0.000466	CcSEcCtD
Clomifene—Pruritus—Doxorubicin—testicular cancer	2.45e-05	0.000461	CcSEcCtD
Clomifene—Vomiting—Epirubicin—testicular cancer	2.38e-05	0.000448	CcSEcCtD
Clomifene—Nausea—Methotrexate—testicular cancer	2.38e-05	0.000447	CcSEcCtD
Clomifene—Diarrhoea—Doxorubicin—testicular cancer	2.37e-05	0.000446	CcSEcCtD
Clomifene—Rash—Epirubicin—testicular cancer	2.36e-05	0.000444	CcSEcCtD
Clomifene—Dermatitis—Epirubicin—testicular cancer	2.36e-05	0.000444	CcSEcCtD
Clomifene—Headache—Epirubicin—testicular cancer	2.35e-05	0.000441	CcSEcCtD
Clomifene—Dizziness—Doxorubicin—testicular cancer	2.29e-05	0.000431	CcSEcCtD
Clomifene—Nausea—Epirubicin—testicular cancer	2.23e-05	0.000418	CcSEcCtD
Clomifene—Vomiting—Doxorubicin—testicular cancer	2.21e-05	0.000414	CcSEcCtD
Clomifene—Rash—Doxorubicin—testicular cancer	2.19e-05	0.000411	CcSEcCtD
Clomifene—Dermatitis—Doxorubicin—testicular cancer	2.19e-05	0.00041	CcSEcCtD
Clomifene—Headache—Doxorubicin—testicular cancer	2.17e-05	0.000408	CcSEcCtD
Clomifene—Nausea—Doxorubicin—testicular cancer	2.06e-05	0.000387	CcSEcCtD
